The explosive growth of the market for consumer wellness products has drawn hundreds—even thousands—of mission-driven entrepreneurs with innovative ideas to improve users’ health.
However, many of these entrepreneurs struggle to find the capital they need to support their companies’ growth once they begin gaining traction in the marketplace. They often need to look beyond traditional equity or debt markets to find a source of capital such as revenue-based financing that makes sense for their specialized requirements.
GROWTH ACROSS MULTIPLE SEGMENTS
Investors and lenders recognize the sector’s growth. McKinsey & Company estimates the consumer wellness market has reached $480 billion a year in the United States, and its growth of 5%-10% a year is driven largely by Gen Z and millennial consumers buying far more wellness products than older generations.
Across the fast-growing market for wellness products, a wide range of segments—health, sleep, nutrition, fitness, appearance, and mindfulness—has generated several new company types. And within each of those segments, a multitude of new products have made their way onto the market—everything from mindfulness apps and juice cleanses to science-based nutritional supplements wrapped up in a subscription model.
STRUGGLE FOR GROWTH CAPITAL
Many of the new products are launched by entrepreneurs who are so committed to their vision of improved wellness that they tap personal bank accounts and retirement funds to get started. In some scenarios, they will lean on personal connections interested in supporting their venture. However, once these consumer wellness startups make it to market with their first products, they struggle to finance the growth they need to scale up and achieve their full potential.
Traditional bank financing seldom is an option. Bankers are not interested in taking on the substantial risks involved in a start-up or early-stage company, especially one with a potentially new product in a rapidly evolving market. Then, too, wellness-related companies often don’t have hard assets such as equipment or real estate that can secure a bank loan. And few can show the history of consistent profitability that banks demand.
VENTURE CAPITAL SCARE
Venture capitalists, meanwhile, generally lack the technical expertise to invest in a wellness-oriented organization, especially as consumers increasingly seek out clinically proven wellness products providing scientific support for their claims. Some wellness companies may be fortunate enough to find a venture capitalist who understands their science and their markets, but new categories of business typically don’t draw significant pools of investors.
A second challenge in the search for venture capital is this: Many wellness-related sectors are so new that venture firms can’t confidently predict their potential return—their multiple—when they exit. Without a good understanding of the exit, they don’t want to come in the entrance.
For wellness-sector entrepreneurs, meanwhile, venture investments may require them to relinquish too much control. A venture firm often requires a seat on the company’s board of directors or a substantial block of voting shares as the price of growth capital. That’s troubling to any entrepreneur, but it’s especially difficult for mission-driven founders of wellness firms who fear outside interference in the pursuit of their vision.
Neither bank loans nor venture funding provide a reliable pathway to growth capital. Non-traditional financing sources such as factors, which buy a company’s receivables at a discount and allow it to get access to cash more quickly, are an option only for companies that already have reached substantial sales volume. They are less useful for growth-stage companies.
THE REVENUE-BASED OPTION
For wellness-related companies in need of capital to fuel growth, revenue-based financing may be a fruitful venture. These loans are structured to require monthly payments that aren’t fixed. Instead, payments represent a specified portion of the borrower’s revenues. If revenues drop for one or two months—a common issue among wellness companies as they build a steady stream of orders—the required repayment drops, too. On the other hand, if revenues climb, the borrower can repay the entire amount more quickly without a prepayment penalty.
It’s important to note that revenue-based financing is debt rather than an equity investment. This is a critical difference because owners are not required to give up any equity, board seats, or corporate control in a revenue-based transaction. Unlike equity investors who expect an exit strategy that promises a quick return, providers of revenue-based financing can be patient. They understand growth plans might take four or five years to come to fruition, and they are not constantly looking to the door to make a profitable exit.
Revenue-based financing packages generally do not require the borrower to guarantee the borrowing personally, and they generally do not require that the company pledge equipment or other hard assets as collateral.
As the wellness market gains even greater momentum, visionary entrepreneurs will develop innovative products to meet consumers’ demands. Equally innovative financial tools such as revenue-based financing will allow them to grow and fulfill their promise.